Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.
about
Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza VaccinesSingle-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 virusesCritical role of perforin-dependent CD8+ T cell immunity for rapid protective vaccination in a murine model for human smallpoxA review of mathematical models of influenza A infections within a host or cell culture: lessons learned and challenges aheadHumoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employeesSuperior in vitro stimulation of human CD8+ T-cells by whole virus versus split virus influenza vaccines.Prior population immunity reduces the expected impact of CTL-inducing vaccines for pandemic influenza control.Cytotoxic T lymphocytes established by seasonal human influenza cross-react against 2009 pandemic H1N1 influenza virus.Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly.Cross-protective immunity to influenza A viruses.Panvax(®): a monovalent inactivated unadjuvanted vaccine against pandemic influenza A (H1N1) 2009.Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.Pseudotyped influenza A virus as a vaccine for the induction of heterotypic immunityNeuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccineInfluenza nucleoprotein delivered with aluminium salts protects mice from an influenza A virus that expresses an altered nucleoprotein sequence.Influenza-specific T cells from older people are enriched in the late effector subset and their presence inversely correlates with vaccine response.Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.Immunization with live attenuated influenza viruses that express altered NS1 proteins results in potent and protective memory CD8+ T-cell responsesMemory CD8+ T cell differentiationShaping successful and unsuccessful CD8 T cell responses following infection.Discovery of novel cross-protective Rickettsia prowazekii T-cell antigens using a combined reverse vaccinology and in vivo screening approachInduction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus.Cationic lipid/DNA complex-adjuvanted influenza A virus vaccination induces robust cross-protective immunityComplement mediated signaling on pulmonary CD103(+) dendritic cells is critical for their migratory function in response to influenza infection.Influenza T-cell epitope-loaded virosomes adjuvanted with CpG as a potential influenza vaccine.Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.Conservation analysis of dengue virus T-cell epitope-based vaccine candidates using Peptide block entropy.Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.Shortened Intervals during Heterologous Boosting Preserve Memory CD8 T Cell Function but Compromise LongevityDiscovering naturally processed antigenic determinants that confer protective T cell immunity.Ex vivo restimulation of human PBMC expands a CD3+CD4-CD8- γδ+ T cell population that can confound the evaluation of CD4 and CD8 T cell responses to vaccination.Protective CD8 T cell-mediated immunity against influenza A virus infection following influenza virus-like particle vaccination.DNA Vaccines Encoding Antigen Targeted to MHC Class II Induce Influenza-Specific CD8(+) T Cell Responses, Enabling Faster Resolution of Influenza Disease.PB1 as a potential target for increasing the breadth of T-cell mediated immunity to Influenza A.Towards the knowledge-based design of universal influenza epitope ensemble vaccines.Memory CD4 T cells: generation, reactivation and re-assignment.SV40 virus-like particles as an effective delivery system and its application to a vaccine carrier.Bioengineering virus-like particles as vaccines.A Review of the Antiviral Susceptibility of Human and Avian Influenza Viruses over the Last Decade.
P2860
Q26783844-8CA17400-0F9E-407D-8CA1-8D96A928DF82Q27318575-C024032E-A10E-40F1-A864-FE08A1C3AF98Q27346933-215FFD3B-E053-4610-AFD7-B3BCA66E3D11Q28382972-F4B55335-826F-433F-9541-A1FABA996C31Q30355654-1DF036B4-D914-437A-8A5D-95E150E83D17Q30365243-6CC58E1D-45D1-4C14-8B67-03AB056A6D21Q30373077-688D0FAB-2BED-4AC1-8BBD-BB32FA65E1F1Q30388401-8C0CCF5F-96A2-43D2-8093-1331CDC31B33Q30391225-9FA44295-1B86-4F5C-B717-ED234E47CEDCQ30396399-B0E310C6-E788-4A65-A39E-44933E74A23DQ30397513-012B364E-850F-4597-B7EC-F3A76C11342AQ30405211-858ED45E-E651-406E-B9F6-FA0EDC89EDD5Q30407851-F529BCC5-FFAC-40CE-A9F3-F899A43868BAQ30421682-807F38A1-6934-4AE0-B63D-7F8DFA44812BQ30425439-B16DFC77-358D-43F3-A8B3-4CAAC5586080Q30429719-04C27218-FFAA-4F30-A14B-5D60FF4A3BCFQ31030019-6E53A730-16A6-4424-AA0F-444B4AEBBC19Q33593103-6B07D56D-F09D-4AD3-AD0B-5A7A4ED1980FQ33614507-D8BB9E29-9CA6-4B70-844E-6100F98449A5Q33720379-68FC4F04-F1B3-4025-AAA8-47D07AAC1BC9Q33771963-14478C80-3882-42FC-8895-49A5CBE81A3EQ34093166-554BA95B-642F-4594-9D97-E55E83D557F6Q34261441-4AA0868E-9513-4D8D-B1DB-B7DC0A8523C5Q34416393-80562AA9-3881-4EE5-90B5-E9601E48DD37Q34550742-069526CB-5F9A-470A-9903-42821B6A7EE3Q35169258-91A87903-9A5F-4242-AE11-B359DE46EB35Q35193959-7AA6899E-1C17-4E31-8DA3-5FAA416CF830Q35927376-183018D3-5601-4692-970C-D9E12D5F2AC1Q36229655-026F6068-E5AB-4CF7-94F9-50C5B27DEA7CQ36706188-2A7BC955-EE43-40A1-8979-12973DE75B29Q36793499-3E2EEAF7-4738-4BAA-855A-D85BE9DCD021Q37162910-076CA31F-CE67-4686-9248-2CB714CE77D5Q37184801-1DEA82A0-CB84-4629-AAB3-9CA2F36F8DAEQ37194981-5E75F6BE-7F4E-406C-B39C-870DA7EF1746Q37319033-10F0634E-0D45-4D23-8F0A-CBAF4E32AC6FQ37365222-3808B932-8970-472F-81D1-AAA8D0D5B455Q37717703-C2C85C6C-C8F4-4E28-8CF3-273181AD0BA7Q38081973-C8CCE835-3EE6-478C-B03C-B176A6E743F4Q38172045-29E2CB8F-7FE2-4E64-AC31-A823334CB193Q38209673-59FDCA33-33AD-40E1-BC1F-F7E4E85F0379
P2860
Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.
@ast
Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.
@en
type
label
Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.
@ast
Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.
@en
prefLabel
Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.
@ast
Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.
@en
P2860
P356
P1476
Prospects for an influenza vaccine that induces cross-protective cytotoxic T lymphocytes.
@en
P2860
P304
P356
10.1038/ICB.2009.16
P577
2009-03-24T00:00:00Z